13 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

PTA, PTV, ATRIOSEPTOSTOMY, ANGIOGRAPHIC, SIZING CATHETERS

FDA 510(k)
FDA Class 2 ·Cardiovascular

N.A.

FDA UDI
Forestadent Bernhard Förster GmbH·EFOR20408301·Arch wires Titanol Superelastic Straight-Arch-F...

i-ED COIL

FDA UDI
KANEKA CORPORATION·04540778177659·The i-ED COIL is used for vascular embolization...

neoWave LS

FDA UDI
XENIX MEDICAL LLC·00818345023888·BAYONETTED PUSH SCRAPER CURETTE

CANNULATION TOURNIQUET SET, 2 TUBE OR 5 TUBE

FDA 510(k)
FDA Class 2 ·Cardiovascular

POWDER FREE TEXTURED VINYL EXAMINATION GLOVES

FDA 510(k)
FDA Class 1 ·General Hospital

COMPLETE

FDA Adverse Event
Injury ·JOHNSON & JOHNSON SURGICAL VISION, INC.·Product code LPN·April 17, 2020

FUSION TITAN DILATION BALLOON

FDA Adverse Event
Malfunction ·COOK INC·Product code FGE·May 4, 2018

ENDOTAK RELIANCE

FDA Adverse Event
Injury ·CPI - DEL CARIBE·Product code NVY·April 8, 2013

PENUMBRA SYSTEM

FDA Adverse Event
Death ·PENUMBRA, INC.·Product code NRY·March 31, 2011

TRAPEZOID RX LITHOTRIPTER COMPATIBLE BASKET

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC CORPORATION·Product code LQC·May 9, 2008

PF-VIRTEC SYSTEM CMTED LAT.6

FDA Adverse Event
Injury ·ZIMMER SWITZERLAND MANUFACTURING GMBH·Product code LZO·August 6, 2019

Quadra Assura, Model No. CD3265-40, CD3265-40Q, CD3365-40C, CD3365-40Q. Quadra Assura MP, Model No. CD3269-40, CD3269-40Q, CD3369-40C. Fortify and Fortify Assura implantable cardioverter defibrillators (ICDS) are intended to provided ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing. Unify and Unify Assura cardiac resynchronization therapy defibrillators (CRTDs) are intended to provide ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing, in additional to cardiac resynchronization therapy via left ventricular pacing

FDA Enforcement
Class I ·Terminated·St Jude Medical Inc.·November 2, 2016